IGF2BP3 and thyroid gland carcinoma: In thyroid cancer, it is rearranged with insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), and this fusion determines high expression of the IGF2BP3 protein, resulting in a deregulated activation of MAPK and PI3K signaling [27,28].